openPR Logo
Press release

Global Opioid Use Disorder Market is projected to reach the value of USD 6.54 billion by 2030

12-20-2023 10:23 AM CET | Health & Medicine

Press release from: Virtue Market Research

Opioid Use Disorder Market

Opioid Use Disorder Market

According to the report published by Virtue Market Research in Global Opioid Use Disorder Market was valued at USD 2.9 billion and is projected to reach a market size of USD 6.54 billion by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 10.7 %.

Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/opioid-use-disorder-market/request-sample

A substantial long-term driver in the Opioid Use Disorder Market is the escalating prevalence of opioid dependency. The persistently high numbers of individuals affected by this disorder necessitate sustained efforts in research, development, and accessibility of effective treatment options. Over the years, this driver has established a sturdy foundation for the market's growth trajectory.

However, the unforeseen emergence of the COVID-19 pandemic posed significant challenges to the market. The pandemic-induced disruptions in healthcare infrastructure, restricted access to treatment facilities, and heightened psychological distress contributed to a surge in opioid use. This unprecedented situation necessitated rapid adaptations and innovative solutions within the industry to mitigate the adverse effects of the pandemic on those struggling with opioid dependency.

In the short term, stringent regulatory frameworks have emerged as a potent driver influencing the Opioid Use Disorder Market. Heightened awareness and increased governmental focus on regulating opioid prescriptions and usage have triggered a shift towards alternative and non-addictive pain management solutions. This shift is propelling the development of innovative therapies and interventions, thus shaping the market's immediate future.

One significant opportunity lies in the integration of telemedicine and digital health solutions in the treatment of opioid use disorder. The advent of virtual platforms has revolutionized healthcare delivery, making treatment more accessible and convenient for patients. This innovation not only enhances patient engagement but also presents an avenue for personalized care, ultimately improving treatment outcomes.

An observed trend within the industry is the growing emphasis on holistic approaches to opioid use disorder management. This trend encompasses a multi-disciplinary approach that combines medication-assisted treatment with behavioral therapies, counseling, and support services. By addressing the physical, mental, and social aspects of addiction, this holistic approach has shown promising results in enhancing long-term recovery rates.

Market Segmentation:
By Drug : Buprenorphine [Sublocade, Belbuca, Suboxone, Zubsolv], Methadone, Naltrexone
Among these, the largest contender is buprenorphine. This medication has gained prominence for its effectiveness in reducing withdrawal symptoms and cravings associated with opioid addiction. Its accessibility and proven results have solidified its position as a cornerstone in opioid addiction therapy. However, when it comes to the fastest-growing drug during the forecast period, methadone takes the lead. With its reliable track record in managing opioid dependency, methadone is anticipated to see substantial growth, offering an alternative avenue for those seeking recovery.

By Route of Administration : Intravenous, Oral
In this context, the largest segment is parenteral administration. This method involves delivering medication directly into the bloodstream, ensuring swift and efficient absorption. Parenteral administration has demonstrated its effectiveness in critical situations, providing immediate relief to individuals grappling with opioid dependence. On the flip side, the fastest-growing route of administration during the forecast period is oral. This approach, involving medication intake through the mouth, is gaining traction due to its convenience and patient-friendly nature. It offers a viable option for individuals seeking a less invasive form of treatment.

By Age : 19 to 40, 41 to 60, and 61 & over
Within the age bracket analysis, the largest segment comprises individuals aged 19 to 40. This demographic represents a substantial portion of those affected by opioid dependency. Factors such as increased exposure to prescription opioids and social environments contribute to this prevalence. Moreover, during the forecast period, the 19 to 40 age group is projected to continue as the fastest-growing segment. This underscores the imperative need for targeted interventions and comprehensive support systems tailored to the unique challenges faced by this age group.

By Distribution Channel : Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies
Among these channels, the largest player is Hospital Pharmacies. These trusted institutions serve as crucial hubs for medication procurement and dispense vital support and guidance to those on the path to recovery. They play an indispensable role in ensuring timely access to treatment. On the other hand, Online Pharmacies emerge as the fastest-growing distribution channel during the forecast period. The digital landscape's increasing influence on healthcare has paved the way for a convenient avenue for individuals to access necessary medications and resources for managing opioid use disorder. This trend signifies a paradigm shift towards more accessible and patient-centric care.

Read More @ https://virtuemarketresearch.com/report/opioid-use-disorder-market

Regional Analysis:
In this context, North America emerges as the largest segment, bearing a substantial burden of opioid dependency cases. The complex interplay of socio-economic factors, healthcare infrastructure, and prescribing practices contribute to this regional distinction. Looking ahead, Asia-Pacific is anticipated to experience the fastest growth during the forecast period. The increasing recognition of opioid-related challenges and concerted efforts in raising awareness and access to treatment options are expected to drive this growth in the Asia-Pacific region.

Latest Industry Developments:
• Companies operating in the Opioid Use Disorder market are increasingly focusing on diversifying their treatment portfolios. This trend involves the development and introduction of novel medications and therapeutic options that address various aspects of opioid dependency. By offering a wider range of effective solutions, companies aim to capture a larger share of the market, catering to the diverse needs and preferences of patients.

• In response to the growing demand for convenient and accessible healthcare, companies are prioritizing the integration of digital health and telemedicine solutions. This trend involves the creation of user-friendly platforms and applications that facilitate remote consultations, medication management, and teletherapy sessions. By leveraging technology, companies seek to not only enhance patient engagement but also expand their reach to underserved populations, thereby strengthening their market presence.

• Recognizing the complex nature of opioid use disorder and the need for comprehensive care, companies are increasingly engaging in collaborative partnerships and alliances. This trend involves forging strategic relationships with healthcare providers, addiction treatment centers, and advocacy groups. By combining resources and expertise, companies aim to create a holistic ecosystem of support for individuals struggling with opioid dependency. This collaborative approach not only fosters innovation but also positions companies as key players in the broader healthcare landscape dedicated to combatting opioid use disorder.

customize the Full Report Based on Your Requirements @ https://virtuemarketresearch.com/report/opioid-use-disorder-market/customization

contact Us:

Virtue Market Research
Kumar Plaza, #103, SRPF Rd, Ramtekadi, Pune, Maharashtra 411013, India
E-mail: megha@virtuemarketresearch.com
Phone: +1-917 436 1025

About Us:
"Virtue Market Research stands at the forefront of strategic analysis, empowering businesses to navigate complex market landscapes with precision and confidence. Specializing in both syndicated and bespoke consulting services, we offer in-depth insights into the ever-evolving interplay between global demand and supply dynamics. Leveraging our expertise, businesses can identify emerging opportunities, discern critical trends, and make decisions that pave the way for future success."

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Opioid Use Disorder Market is projected to reach the value of USD 6.54 billion by 2030 here

News-ID: 3333505 • Views:

More Releases from Virtue Market Research

Global Book Subscription Box Market is projected to reach the value of USD 19.59 billion by 2030
Global Book Subscription Box Market is projected to reach the value of USD 19.59 …
According to the report published by Virtue Market Research in Book Subscription Box Market was valued at USD 10.2 billion and is projected to reach a market size of USD 19.59 billion by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 8.5%. Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/book-subscription-box-market/request-sample A prominent long-term market driver in the
Global Charcoal Market is projected to reach the value of USD 11.58 billion by 2030
Global Charcoal Market is projected to reach the value of USD 11.58 billion by 2 …
According to the report published by Virtue Market Research in Charcoal Market was valued at USD 8.4 billion and is projected to reach a market size of USD 11.58 billion by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 4.09%. Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/charcoal-market/request-sample One of the long-term market drivers in the Charcoal
Global 5G Voice over New Radio (VoNR) Market is projected to reach the value of USD 1.1 billion by 2030
Global 5G Voice over New Radio (VoNR) Market is projected to reach the value of …
According to the report published by Virtue Market Research in 5G Voice over New Radio (VoNR) Market was valued at USD 195 million and is projected to reach a market size of USD 1.1 billion by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 25.1%. Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/5g-voice-over-new-radio-market/request-sample One of the most influential
Global Oxygen Scavengers Market is projected to reach the value of USD 4.33 billion by 2030
Global Oxygen Scavengers Market is projected to reach the value of USD 4.33 bill …
According to the report published by Virtue Market Research in Global Oxygen Scavengers Market was valued at USD 2.8 billion and is projected to reach a market size of USD 4.33 billion by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 5.6 %. Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/global-oxygen-scavengers-market/request-sample One of the enduring driving forces behind

All 5 Releases


More Releases for Opioid

Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Opioid-Induced Constipation Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for treatment of opioid-induced constipation has seen a substantial growth recently. It is expected to escalate from a solid $1.78 billion in 2024 to an impressive $1.9 billion in 2025, exhibiting
Growing Number Of Opioid Addiction Cases: Strategic Insights Driving Opioid Use …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Opioid Use Disorder (OUD) Market Size By 2025? The market size for opioid use disorder (OUD) has experienced a quick expansion in the past few years. The growth is projected to rise from $3.96 billion in 2024 to $4.39 billion in 2025, boasting a compound
Key Influencer in the Opioid-Induced Constipation Treatment Market 2025: Rising …
What combination of drivers is leading to accelerated growth in the opioid-induced constipation treatment market? The rise in opioid administration for cancer and non-cancer pain is expected to drive the growth of the opioid-induced constipation (OIC) treatment market. Opioids are commonly used for managing moderate to severe pain, but they can cause constipation. OIC treatments are vital for improving the quality of life for patients on opioids, allowing them to maintain
Top Factor Driving Opioid Use Disorder (OUD) Market Growth in 2025: Growing Numb …
How Are the key drivers contributing to the expansion of the opioid use disorder (oud) market? The rise in instances of opioid dependency is set to fuel the expansion of the opioid use disorder (OUD) market. Opioid dependency defines a health concern marked by habitual and uncontrolled opioid consumption which negatively impacts health. These opioids can generate feelings of bliss and relief from pain, but continued usage often results in tolerance
What's Driving the Opioid-Induced Constipation Treatment Market 2025-2034: Risin …
What Are the Projections for the Size and Growth Rate of the Opioid-Induced Constipation Treatment Market? The market size for treatments of constipation caused by opioids has seen robust growth lately. The forecasted growth indicates an increase from $1.78 billion in 2024 to $1.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%. This past growth is associated with a growing elderly population, individualized treatments for OIC, the
MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana. Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622 Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal